시장보고서
상품코드
1757713

세계의 혈관내 동맥류 수복술 시장

Endovascular Aneurysm Repair

발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 276 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

혈관내 동맥류 수복술 세계 시장은 2030년까지 30억 달러에 달할 전망

2024년에 25억 달러로 추정되는 혈관내 동맥류 수복술 세계 시장은 2024-2030년 분석 기간 동안 CAGR 3.3%로 성장하여 2030년에는 30억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 복부 대동맥류는 CAGR 3.0%를 기록하며 분석 기간 종료시에는 16억 달러에 달할 것으로 예측됩니다. 흉부 대동맥류 부문의 성장률은 분석 기간 CAGR로 3.9%로 추정됩니다.

미국 시장은 6억 7,760만 달러로 추정, 중국은 CAGR 6.1%로 성장 예측

미국의 혈관내 동맥류 수복술 시장은 2024년에 6억 7,760만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 5억 9,680만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 6.1%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.3%와 2.5%로 예측됩니다. 유럽에서는 독일이 CAGR 1.9%로 성장할 것으로 예측됩니다.

세계의 혈관내 동맥류 수복술 시장 - 주요 동향과 촉진요인 정리

혈관내 동맥류 수복술이 혈관 의료에서 동맥류 치료를 재정의하는 이유는 무엇일까?

혈관내 동맥류 수복술(EVAR)은 기존의 개복 수술을 대체할 수 있는 최소침습적 치료법을 제공함으로써 복부 및 흉부 대동맥류 관리에 혁명을 일으켰습니다. 이 시술은 사타구니의 작은 절개창을 통해 스텐트 이식편을 삽입하여 대퇴동맥을 통해 동맥류 부위까지 이동시킨 후, 그곳에서 스텐트 이식편을 전개하여 약해진 혈관벽을 보강하고 파열을 방지하는 방식으로, 개복수술에 비해 출혈량 감소, 수술 전후 이환율 감소, 입원기간 단축, 회복시간 단축 등 많은 이점이 있습니다. 회복시간 단축 등 많은 장점이 있습니다. 특히 고령의 환자나 합병증이 있어 대수술을 견딜 수 없는 환자에게 유리합니다. 인구 고령화, 고혈압, 흡연, 동맥경화증 등으로 인한 대동맥류 발생률이 전 세계적으로 증가함에 따라 EVAR과 같은 보다 안전하고 효율적인 중재시술에 대한 임상적 요구가 크게 증가하고 있습니다. 혈관 영상과 스텐트 그래프트의 디자인이 지속적으로 개선됨에 따라, EVAR은 적절한 해부학적 구조를 가진 많은 환자들에게 첫 번째 선택 치료법이 되고 있습니다. 또한, 스크리닝 프로그램의 보급과 영상 진단의 개선으로 무증상 동맥류의 조기 발견이 가능해짐에 따라 EVAR의 잠재적 치료 대상이 확대되고 있습니다. 그 결과, EVAR은 동맥류 치료 방법을 변화시켰을 뿐만 아니라, 회복과 장수를 위한 저위험 고수익의 길을 제공함으로써 환자의 기대를 재구성하고 있습니다.

기술 혁신은 EVAR 시술의 정확성과 치료 결과를 어떻게 향상시키고 있는가?

혈관내 동맥류 수복술 분야는 스텐트 이식편 디자인, 영상 기술 및 시술의 끊임없는 혁신에 힘입어 빠르게 발전하고 있습니다. 최신 스텐트 그래프트는 유연성, 내구성, 적합성이 뛰어나며, 구불구불한 혈관이나 각진 혈관을 포함한 다양한 환자 해부학적 구조에 대응할 수 있도록 설계되어 있습니다. 레일형 스텐트 그래프트와 분지형 스텐트 그래프트의 등장으로 신장동맥, 장골동맥 등 주요 동맥 분지를 포함하거나 이에 근접한 동맥류 치료가 가능해져 이전에는 EVAR에 적합하지 않다고 여겨졌던 환자도 치료할 수 있게 되었습니다. 퓨전 이미징 및 혈관내 초음파(IVUS)와 같은 실시간 3D 영상 유도 내비게이션 시스템은 이식편 설치의 정확도를 획기적으로 향상시키고 합병증과 조영제의 필요성을 감소시켰습니다. 로봇 보조 및 카테터 기반 전달 시스템은 특히 복잡한 대동맥 해부학적 구조에서 정확도와 조작자 제어를 향상시키고 있습니다. 생체흡수성 재료 및 약물 용출성 스텐트 기술 혁신도 이식편과의 통합을 개선하고 이식편 누출 및 이식편 이동과 같은 장기적인 위험을 줄이기 위해 연구되고 있습니다. 원격 추적 관찰과 합병증 조기 발견을 가능하게 하는 웨어러블 기술과 모바일 헬스 플랫폼의 발전으로 시술 후 모니터링도 혜택을 받고 있습니다. 이러한 기술 혁신은 EVAR 시술의 안전성과 유효성을 향상시킬 뿐만 아니라 적용 범위를 넓혀 혈관 내 치료의 한계를 뛰어넘고 있습니다.

왜 EVAR에 대한 수요가 인구통계와 전 세계 지역에 걸쳐 확대되고 있는가?

혈관내 동맥류 수복술에 대한 수요는 임상적, 경제적, 인구통계학적 요인이 복합적으로 작용하여 연령대, 환자 프로필, 지리적 지역을 초월하여 빠르게 증가하고 있습니다. 고소득 국가에서는 고령화가 주요 원동력이 되고 있으며, 특히 65세 이상 남성은 복부 대동맥류(AAA)의 위험이 높습니다. 이들 국가에서는 이미 확립된 검진 프로그램, 고급 영상 진단 능력, 전문 혈관 센터에 대한 접근성 등의 이점이 있어 파열이 발생하기 전에 조기에 진단하고 선택적으로 EVAR을 시행할 수 있습니다. 반면, 신흥국에서는 당뇨병, 고혈압, 흡연 등 심혈관 위험인자가 급증하면서 동맥류의 부담이 증가하고 있습니다. 의료 인프라가 개선되고 혈관 내 치료에 대한 접근성이 높아짐에 따라 이들 시장은 EVAR 기술에 큰 성장 기회가 될 것입니다. 또한, EVAR의 채택은 훈련의 발전, 시술의 표준화, 간소화된 스텐트 이식 시스템 등에 힘입어 3차 의료 센터뿐만 아니라 지역 병원과 동네 병원까지 확대되고 있습니다. 또한, 환자들도 치료 결정에 있어 보다 적극적인 역할을 하고 있으며, 많은 환자들이 회복이 빠르고 수술 후 통증이 적은 최소침습적 치료법을 선호하고 있습니다. 결합조직 손상이나 외상성 대동맥 손상이 있는 젊은 환자에서 EVAR의 적응증 외 사용이 검토되고 있으며, 유망한 결과를 보이고 있습니다. 군 의료부터 재난 대응 및 이동 수술실까지, EVAR의 다재다능함은 다양한 의료 환경에 대한 적응성을 높여 전 세계 수요를 더욱 촉진하고 있습니다.

혈관내 동맥류 수복술 시장의 성장 가속화 요인은?

혈관내 동맥류 수복술 시장의 성장은 기술적, 임상적, 경제적, 규제적 요인이 복합적으로 작용하고 있으며, 이러한 요인들은 종합적으로 이 분야의 확대와 성숙을 가리키고 있습니다. 가장 중요한 성장 요인 중 하나는 특히 고령화 사회와 심혈관 위험 요인을 가진 사람들 사이에서 대동맥류 유병률이 증가하고 있다는 것입니다. 합병증 발생률이 낮고, 회복 시간이 짧고, 병원 자원 사용량이 적기 때문에 점점 더 많은 의료 서비스 제공자가 개복 수술보다 EVAR을 선택하고 있습니다. 규제 당국의 승인 및 상환 정책도 중요한 역할을 하고 있으며, 더 많은 EVAR 장비가 더 넓은 해부학적 적응증으로 승인되고 보험 적용 계획에 통합되고 있습니다. 외래 혈관 수술 센터와 하이브리드 수술실의 등장으로 병원이 대규모 인프라 구축 없이도 EVAR을 도입할 수 있는 여건이 조성되고 있습니다. 또한, 동맥류 증상, 위험 요인, 검진 권장사항에 대한 의사와 환자 모두의 인식이 높아짐에 따라 조기 진단과 적시 개입이 가능해졌습니다. 의료기기 제조업체들은 차세대 이식 및 전달 시스템을 개발하기 위해 연구개발에 많은 투자를 하고 있으며, 시술의 복잡성과 장기적인 합병증을 줄일 수 있는 혁신적인 기술 파이프라인을 구축하고 있습니다. 임상 가이드라인이 최소침습적 솔루션을 지속적으로 지지하고 전 세계 의료 시스템이 예방적 치료로 전환함에 따라, EVAR은 성숙 시장과 신흥 시장 모두에서 지속적이고 높은 성장세를 유지할 준비가 되어 있습니다.

부문

적응증(복부 대동맥류, 흉부 대동맥류, 기타 적응증), 제품(경피적 EVAR, 천공형 EVAR, 대동맥 스텐트 및 TAA 그래프트, 기타 제품)

조사 대상 기업 사례(총 36개사)

  • Abbott Laboratories
  • Bolton Medical, Inc.
  • Boston Scientific Corporation
  • C.R. Bard(a BD company)
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Cordis Corporation(Johnson & Johnson)
  • Endologix, Inc.
  • Endospan Ltd.
  • Getinge AB
  • JOTEC GmbH
  • L. Gore & Associates, Inc.(Gore Medical)
  • Lombard Medical Limited
  • Medtronic plc
  • Philips Healthcare
  • Shanghai MicroPort Medical(Group) Co., Ltd.
  • Teleflex Incorporated
  • Terumo Corporation
  • TriVascular Technologies, Inc.
  • Volcano Corporation(a Philips company)

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 산업별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.07.03

Global Endovascular Aneurysm Repair Market to Reach US$3.0 Billion by 2030

The global market for Endovascular Aneurysm Repair estimated at US$2.5 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Abdominal Aortic Aneurysm, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Thoracic Aortic Aneurysm segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$677.6 Million While China is Forecast to Grow at 6.1% CAGR

The Endovascular Aneurysm Repair market in the U.S. is estimated at US$677.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$596.8 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Endovascular Aneurysm Repair Market - Key Trends & Drivers Summarized

Why Is Endovascular Aneurysm Repair Redefining Aneurysm Treatment in Vascular Medicine?

Endovascular Aneurysm Repair (EVAR) has revolutionized the management of abdominal and thoracic aortic aneurysms by providing a minimally invasive alternative to traditional open surgical repair. This technique involves inserting a stent graft through a small incision in the groin and navigating it via the femoral artery to the site of the aneurysm, where it is deployed to reinforce the weakened vessel wall and prevent rupture. EVAR offers numerous benefits over open surgery, including reduced blood loss, lower perioperative morbidity, shorter hospital stays, and faster recovery times. It is especially advantageous for elderly patients or those with comorbidities who may not tolerate major surgery. The rising global incidence of aortic aneurysms-driven by aging populations, hypertension, smoking, and atherosclerosis-has significantly increased the clinical need for safer, more efficient interventions like EVAR. As vascular imaging and stent-graft design continue to improve, EVAR has become the first-line treatment for many patients with suitable anatomy. Additionally, widespread screening programs and improved diagnostic imaging have led to earlier detection of asymptomatic aneurysms, expanding the potential candidate pool for EVAR procedures. As a result, EVAR is not only transforming how aneurysms are treated but also reshaping patient expectations by offering a lower-risk, high-reward path to recovery and longevity.

How Are Technological Innovations Enhancing the Precision and Outcomes of EVAR Procedures?

The field of endovascular aneurysm repair is advancing rapidly, fueled by continual innovations in stent graft design, imaging technologies, and procedural techniques. Modern stent grafts are now designed with greater flexibility, durability, and conformability to accommodate a wider range of patient anatomies, including those with tortuous or angulated vessels. The advent of fenestrated and branched stent grafts has made it possible to treat aneurysms that involve or are close to major arterial branches such as the renal and iliac arteries-cases that were previously deemed unsuitable for EVAR. Real-time 3D image-guided navigation systems, such as fusion imaging and intravascular ultrasound (IVUS), have dramatically improved the accuracy of graft placement, reducing complications and the need for contrast agents. Robotic-assisted and catheter-based delivery systems are enhancing precision and operator control, particularly in complex aortic anatomies. Innovations in bioresorbable materials and drug-eluting stents are also being explored to improve graft integration and reduce long-term risks such as endoleaks or graft migration. Post-procedural monitoring has benefited from advancements in wearable technology and mobile health platforms, which allow for remote follow-up and early detection of complications. Collectively, these innovations are not only improving the safety and efficacy of EVAR procedures but also expanding their applicability, pushing the boundaries of what can be achieved through endovascular intervention.

Why Is the Demand for EVAR Expanding Across Demographics and Global Regions?

The demand for endovascular aneurysm repair is expanding rapidly across age groups, patient profiles, and geographic regions due to a combination of clinical, economic, and demographic factors. In high-income countries, the aging population is a key driver, with men over 65 being particularly at risk for abdominal aortic aneurysms (AAA). These nations also benefit from established screening programs, advanced imaging capabilities, and access to specialized vascular centers, enabling early diagnosis and elective EVAR before rupture occurs. In contrast, emerging economies are seeing a surge in cardiovascular risk factors-including diabetes, hypertension, and smoking-contributing to a growing aneurysm burden. As healthcare infrastructure improves and access to endovascular procedures increases, these markets represent significant growth opportunities for EVAR technologies. Moreover, the adoption of EVAR is extending beyond tertiary care centers to regional and community hospitals, supported by advancements in training, procedural standardization, and simplified stent-graft systems. Patients are also playing a more active role in treatment decisions, with many favoring minimally invasive options that allow for quicker recovery and less postoperative pain. In younger patients with connective tissue disorders or traumatic aortic injuries, off-label use of EVAR is being explored with promising outcomes. From military medicine to disaster response and mobile surgical units, the versatility of EVAR makes it highly adaptable across diverse healthcare environments, further driving global demand.

What Factors Are Fueling the Accelerated Growth of the Endovascular Aneurysm Repair Market?

The growth in the endovascular aneurysm repair market is driven by a convergence of technological, clinical, economic, and regulatory factors that collectively point to an expanding and maturing field. One of the most significant growth drivers is the increasing prevalence of aortic aneurysms, particularly in aging populations and among individuals with cardiovascular risk factors. Healthcare providers are increasingly opting for EVAR over open surgery due to its lower complication rates, shorter recovery time, and reduced hospital resource utilization-factors that align well with value-based healthcare models and cost-containment initiatives. Regulatory approvals and reimbursement policies are also playing a crucial role, with more EVAR devices receiving clearance for broader anatomical indications and being included in insurance coverage plans. The rise of outpatient vascular surgery centers and hybrid operating rooms has made it more feasible for hospitals to adopt EVAR without major infrastructure overhauls. Additionally, increased awareness among both physicians and patients regarding aneurysm symptoms, risk factors, and screening recommendations is driving earlier diagnosis and timely intervention. Medical device companies are investing heavily in R&D to develop next-generation grafts and delivery systems, creating a pipeline of innovations that promise to reduce procedural complexity and long-term complications. As clinical guidelines continue to favor minimally invasive solutions and global healthcare systems pivot toward proactive, preventative care, EVAR is poised for sustained, high-growth momentum across both mature and emerging markets.

SCOPE OF STUDY:

The report analyzes the Endovascular Aneurysm Repair market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Other Indications); Product (Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft, Other Products)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Abbott Laboratories
  • Bolton Medical, Inc.
  • Boston Scientific Corporation
  • C.R. Bard (a BD company)
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Cordis Corporation (Johnson & Johnson)
  • Endologix, Inc.
  • Endospan Ltd.
  • Getinge AB
  • JOTEC GmbH
  • L. Gore & Associates, Inc. (Gore Medical)
  • Lombard Medical Limited
  • Medtronic plc
  • Philips Healthcare
  • Shanghai MicroPort Medical (Group) Co., Ltd.
  • Teleflex Incorporated
  • Terumo Corporation
  • TriVascular Technologies, Inc.
  • Volcano Corporation (a Philips company)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Endovascular Aneurysm Repair - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Aging Patient Population Throws the Spotlight on Minimally Invasive Aneurysm Repair Options
    • Rising Prevalence of Abdominal Aortic Aneurysms Propels Growth in Endovascular Treatment Adoption
    • Preference for Shorter Hospital Stays Expands Addressable Market for EVAR Procedures
    • Innovation in Stent Graft Design Strengthens the Business Case for Complex Aneurysm Treatment
    • Advances in Imaging and Navigation Systems Accelerate Demand for Precision-Guided Repairs
    • Surge in Outpatient Vascular Procedures Sustains Growth in Ambulatory EVAR Solutions
    • Growing Surgeon Comfort with Endovascular Techniques Spurs Wider Adoption in Community Hospitals
    • Post-EVAR Monitoring Requirements Generate Opportunities for Device-Enabled Surveillance Systems
    • Rising Use of Custom and Fenestrated Grafts Expands Treatment in Anatomically Challenging Cases
    • Technology Convergence in Robotics and Endovascular Tools Enhances Precision and Outcomes
    • High-Risk Patient Demographics Create Market for EVAR as Preferred Alternative to Open Surgery
    • Global Expansion of Vascular Surgery Infrastructure Fuels EVAR Penetration in Emerging Regions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Endovascular Aneurysm Repair Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Endovascular Aneurysm Repair by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Abdominal Aortic Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Abdominal Aortic Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Abdominal Aortic Aneurysm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Thoracic Aortic Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Thoracic Aortic Aneurysm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Thoracic Aortic Aneurysm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Percutaneous EVAR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Percutaneous EVAR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Percutaneous EVAR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Fenestrated EVAR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Fenestrated EVAR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Fenestrated EVAR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Aortic Stents & TAA Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Aortic Stents & TAA Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Aortic Stents & TAA Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • JAPAN
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • CHINA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • EUROPE
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Endovascular Aneurysm Repair by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • FRANCE
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • GERMANY
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • INDIA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Endovascular Aneurysm Repair by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Endovascular Aneurysm Repair by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030
  • AFRICA
    • Endovascular Aneurysm Repair Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Endovascular Aneurysm Repair by Indication - Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Endovascular Aneurysm Repair by Indication - Percentage Breakdown of Value Sales for Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and Other Indications for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Endovascular Aneurysm Repair by Product - Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Endovascular Aneurysm Repair by Product - Percentage Breakdown of Value Sales for Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft and Other Products for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제